Astria Therapeutics, Inc. (ATXS)

Astria Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	172.01	175.53	20.53	86.51	24.93	9.9
Short-Term Investments	197.9	71	205.91	39	20	26.35
Cash & Cash Equivalents	369.91	246.53	226.44	125.51	44.93	36.24
Cash Growth	73.40%	8.87%	80.42%	179.34%	23.97%	-3.53%
Other Current Assets	4.61	4.41	1.25	1.57	1.4	2.71
Total Current Assets	374.52	250.94	227.69	127.08	46.33	38.96
Property, Plant & Equipment	0.21	0.36	0.95	0.39	0.97	2.35
Other Long-Term Assets	4.08	3.36	2	0.05	0.17	0.47
Total Long-Term Assets	4.29	3.72	2.94	0.44	1.13	2.82
Total Assets	378.81	254.67	230.63	127.51	47.46	41.78
Accounts Payable	0.86	1.51	0.79	1.56	1.54	1.2
Current Debt	0.17	0.33	0.58	0.37	0.65	1.23
Other Current Liabilities	10.04	9.71	7.69	3.28	4.2	2.61
Total Current Liabilities	11.07	11.55	9.06	5.2	6.39	5.03
Long-Term Debt	0	0	0.36	0	0.4	1.03
Total Long-Term Liabilities	0	0	0.36	0	0.4	1.03
Total Liabilities	11.07	11.55	9.42	5.2	6.79	6.06
Total Debt	0.17	0.33	0.94	0.37	1.05	2.25
Debt Growth	-78.84%	-64.96%	157.26%	-65.11%	-53.57%	-
Retained Earnings	-600.46	-580.53	-507.64	-455.81	-260.9	-223.6
Comprehensive Income	-0.01	0	-0.08	0	0	0
Shareholders' Equity	367.74	243.12	221.22	122.31	40.67	35.72
Net Cash / Debt	369.74	246.2	225.5	125.14	43.88	33.99
Net Cash / Debt Growth	73.97%	9.18%	80.19%	185.17%	29.10%	-9.53%
Net Cash Per Share	7.07	8.17	15.42	14.02	14.35	18.21
Working Capital	363.45	239.39	218.63	121.87	39.94	33.93
Book Value Per Share	7.03	8.07	15.13	13.70	13.30	19.14

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).